Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies
False-positive and false-negative results are prevalent in cancer antigen 125 (CA-125) and PET/CT testing for adult patients with newly diagnosed idiopathic inflammatory myopathy. Understanding the causes of these inaccuracies can aid clinicians in making informed decisions during patient care.
Authors
- Christopher A. Mecoli (ORCID: https://orcid.org/0000-0002-1429-8392)
- Andrew Lee Mammen (ORCID: https://orcid.org/0000-0003-3732-3252)
- Brittany L. Adler (ORCID: https://orcid.org/0000-0001-9912-2435)
- Eleni Tiniakou (ORCID: https://orcid.org/0000-0003-4749-870X)
- XingYao Wang (ORCID: https://orcid.org/0000-0001-9993-8864)
- Julie J. Paik (ORCID: https://orcid.org/0000-0001-8436-1601)
- Lisa Christopher‐Stine (ORCID: https://orcid.org/0000-0002-7150-7306)
- Jemima Albayda (ORCID: https://orcid.org/0000-0002-8030-9504)
Institutions
- National Institutes of Health (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1093/rheumatology/keae470
- Citations
- 2
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- National Institutes of Health